Kaoru Koike1, Kazuhiko Sekine, Tomoyuki Endo
1Department of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Preclinical sepsis models often fail to predict clinical efficacy of immunomodulatory agents. Revised animal models, including modified intravenous and peritonitis approaches with supportive care, may offer better translation to human sepsis treatment.
Area of Science:
Context:
Purpose:
Summary:
Impact: